Stuart Evan Seropian MD

Associate Professor of Medicine (Hematology)

Clinical Interests

Hodgkin's disease; Non-Hodgkin's Lymphoma (NHL); multiple myeloma; bone marrow transplant; stem cell transplant


Board Certifications

1997
Medical Oncology, Board Certified

Patient Care Locations

 
stuart_seropianfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Hepatic Veno-Occlusive Disease Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Graft Versus Host Disease, Myelodysplastic Syndromes, Leukemia, not otherwise specified, and Non-Hodgkin's Lymphoma A Multicenter, Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's Lymphoma Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Myeloid and Monocytic Leukemia E2905: Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia

More Clinical Trials...

Edit Profile